TilrayTLRY
TLRY
About: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
Employees: 2,842
0
Funds holding %
of 7,429 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
14% more call options, than puts
Call options by funds: $3.5M | Put options by funds: $3.09M
0.09% less ownership
Funds ownership: 9.81% [Q1] → 9.72% (-0.09%) [Q2]
1% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 74
6% less funds holding
Funds holding: 328 [Q1] → 309 (-19) [Q2]
26% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 53
32% less capital invested
Capital invested by funds: $60.4M [Q1] → $40.9M (-$19.5M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$2
44%
upside
Avg. target
$2
44%
upside
High target
$2
44%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Jefferies Kaumil Gajrawala | 44%upside $2 | Buy Maintained | 25 Aug 2025 |
Financial journalist opinion
Based on 33 articles about TLRY published over the past 30 days
Positive
MarketBeat
4 days ago
Tilray's High Hopes: The Catalyst Driving Cannabis Stocks
A fairly consistent climb in Tilray Brands' NASDAQ: TLRY stock price has started to capture the market's attention. After touching a 52-week low of 35 cents, the stock has rallied dramatically, climbing over 133% in the last three months on massive trading volume.
Neutral
GlobeNewsWire
5 days ago
Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir
Mountain Shot Delivers an Elevated Whiskey Experience, Blending Smooth Chocolate Notes with a Refreshing Hint of Mint Mountain Shot Delivers an Elevated Whiskey Experience, Blending Smooth Chocolate Notes with a Refreshing Hint of Mint
Positive
The Motley Fool
6 days ago
If You'd Invested $1,000 in Tilray Stock 5 Years Ago, Here's How Much You'd Have Today
The cannabis industry experienced significant regulatory progress toward the end of the last decade, arguably none more important than Canada's legalization of recreational uses of the substance in 2018. This move attracted the attention of investors who rushed to purchase shares of notable cannabis companies, including Tilray Brands (TLRY -7.46%).
Positive
The Motley Fool
6 days ago
President Trump Is Considering Rescheduling Cannabis. Is Now the Time to Load Up on Pot Stocks?
It's happening again. The cycle of pot stocks surging on news related to potential cannabis reform.
Positive
MarijuanaStocks
1 week ago
Best Canadian Cannabis Stocks in 2025
Canada's leading cannabis firms with U.S. exposure are gaining fresh attention. Their ability to bridge both markets gives them an advantage. Moreover, U.S. policy shifts could provide new momentum. Rescheduling marijuana to a lower classification may ease banking access. In addition, that change would reduce tax burdens for licensed businesses. These potential reforms could unlock stronger growth.
Neutral
Zacks Investment Research
1 week ago
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.03, denoting a -12.71% move from the preceding trading day.
Positive
Seeking Alpha
1 week ago
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Neutral
GlobeNewsWire
1 week ago
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements
NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq's listing standards regarding its price per share. The Company is evaluating several options including, but not limited to, a stockholder-approved Reverse Stock Split to address capital structure and maintain adherence to Nasdaq's continued listing requirements.
Neutral
The Motley Fool
1 week ago
2 Stocks Down More Than 90% That Still Aren't Worth Buying
While basic investing wisdom advises us to "buy low," no point is low enough when there's hardly any hope that a stock will bounce back. In other words, no matter how much a company lags the market, sometimes it still isn't attractive.
Neutral
GlobeNewsWire
1 week ago
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
Tilray's FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies Tilray's FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies
Charts implemented using Lightweight Charts™